Stockreport

Evogene and Shanghai Lishan Biopharmaceuticals Co. Announce Exclusive Licensing Agreement for BMC128, a Microbiome-Based Therapeutic for Renal and Lung Cancer [Yahoo! Finance]

Evogene Ltd. - Ordinary Shares  (EVGN) 
Last evogene ltd. - ordinary shares earnings: 2/28 07:00 am Check Earnings Report
US:NYSE Investor Relations: evogene.com/investor-relations
PDF REHOVOT, Israel and SHANGHAI Feb. 4, 2026 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN) ("Evogene"), a pioneering computational chemistry company specializin [Read more]